BDNF and DARPP-32 genes are not risk factors for schizophrenia in the Malay population

Genetics and Molecular Research

Volumn 11, Issue 1, 2012, Pages 725-730

  Loh, H C ^a,b   Tang, P Y ^a   Tee, S F ^a   Chow, T J ^a   Cheah, Y C ^c   Singh, S S J ^c  

^a UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c Hospital Bahagia Ulu Kinta   (Malaysia)

Author keywords

BDNF; DARPP; Restriction fragment length polymorphism; Schizophrenia; SNP

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PHOSPHOPROTEIN DARPP 32;

ADULT; ARTICLE; BRAIN DERIVED NEUROTROPHIC FACTOR GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINE AND CAMP REGULATED PHOSPHOPROTEIN 32 GENE; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALAY; MALE; NEUROPATHOLOGY; POPULATION RISK; RISK ASSESSMENT; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALAYSIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA;

EID: 84864082103     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.March.22.2     Document Type: Article

References (27)

1. Albert KA, Hemmings HC, Adamo AI, Potkin SG, et al. (2002). Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch. Gen. Psychiatry 59: 705-712.
2. Angelucci F, Brene S and Mathe AA (2005). BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry 10: 345-352.
3. Chen ZY, Jing D, Bath KG, Ieraci A, et al. (2006). Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314: 140-143.
4. Egan MF, Weinberger DR and Lu B (2003). Schizophrenia, III: brain-derived neurotropic factor and genetic risk. Am. J. Psychiatry 160: 1242.
5. Fienberg AA, Hiroi N, Mermelstein PG, Song W, et al. (1998). DARPP-32: regulator of the effcacy of dopaminergic neurotransmission. Science 281: 838-842.
6. Gratacòs M, González JR, Mercader JM, de Cid R, et al. (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confrm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 61: 911-922.
7. Hong CJ, Yu YW, Lin CH and Tsai SJ (2003). An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 349: 206-208.
8. Jonsson EG, Edman-Ahlbom B, Sillen A, Gunnar A, et al. (2006). Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog. Neuropsychopharmacol. Biol. Psychiatry 30: 924-933.
9. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, et al. (2007). Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatry Genet. 17: 165-170.
10. Li CH, Liao HM, Hung TW and Chen CH (2006). Mutation analysis of DARPP-32 as a candidate gene for schizophrenia. Schizophr. Res. 87: 1-5.
11. Meyer-Lindenberg A, Straub RE, Lipska BK, Verchinski BA, et al. (2007). Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J. Clin. Invest. 117: 672-682.
12. Muglia P, Vicente AM, Verga M, King N, et al. (2003). Association between the BDNF gene and schizophrenia. Mol. Psychiatry 8: 146-147.
13. Murray RM, Sham P, van Os J, Zanelli J, et al. (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr. Res. 71: 405-416.
14. Nanko S, Kunugi H, Hirasawa H, Kato N, et al. (2003). Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr. Res. 62: 281-283.
15. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, et al. (2005). BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 10: 208-212.
16. Nishi A, Watanabe Y, Higashi H, Tanaka M, et al. (2005). Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proc. Natl. Acad. Sci. U. S. A. 102: 1199-1204.
17. Qian L, Zhao J, Shi Y, Zhao X, et al. (2007). Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochem. Biophys. Res. Commun. 353: 738-743.
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, et al. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 (SUPPL. 20): 22-33.
19. Skibinska M, Hauser J, Czerski PM, Leszczynska-Rodziewicz A, et al. (2004). Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J. Biol. Psychiatry 5: 215-220.
20. Squassina A, Piccardi P, Del Zompo M, Rossi A, et al. (2010). NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample. Psychiatry Res. 176: 82-84.
21. Svenningsson P, Tzavara ET, Liu F, Fienberg AA, et al. (2002). DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc. Natl. Acad. Sci. U. S. A. 99: 3188-3193.
22. Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, et al. (2002). Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fuoxetine (Prozac). Proc. Natl. Acad. Sci. U. S. A. 99: 3182-3187.
23. Takahashi T, Suzuki M, Tsunoda M, Kawamura Y, et al. (2007). Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neurosci. Lett. 435: 34-39.
24. Tee SF, Chow TJ, Tang PY and Loh HC (2010). Linkage of schizophrenia with TPH2 and 5-HTR2A gene polymorphisms in the Malay population. Genet. Mol. Res. 9: 1274-1278.
25. Tee SF, Tang PY and Loh HC (2011). No evidence for association between DRD3 and COMT with schizophrenia in a Malay population. Genet. Mol. Res. 10: 1850-1855.
26. Tee SF, Tang PY and Loh HC (2012). COMT haplotype analyses in Malaysian with schizophrenia. Psychiatry Res. 195: 83-84.
27. Xu MQ, St Clair D, Ott J, Feng GY, et al. (2007). Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr. Res. 91: 6-13.